Literature DB >> 10082203

Transient and sustained impacts of hydroxyl radicals on sarcoplasmic reticulum function: protective effects of nebivolol.

P M Janssen1, O Zeitz, G Hasenfuss.   

Abstract

The hydroxyl radical (*OH) is a very reactive oxygen-free radical species that has profound effects on myocardial contractility. We investigated the impact of *OH on free radical induced injury in right ventricular rabbit cardiac trabeculae. Additionally, we investigated the protective properties of the beta-adrenoceptor antagonist nebivolol. The contractile response to a brief, 2 min exposure to *OH consisted of a severe but transient rigor-like contracture, followed by a new steady state in which diastolic force (Fdia) remained increased and developed force (Fdev) remained decreased. In the new steady state sarcoplasmic reticulum function only partly recovered, reflected by a > 50% blunted force-frequency relationship. In the presence of nebivolol (10(-6) M), during the early phase the increase in Fdia was significantly smaller, and recovered better while Fdev was higher during peak. Moreover, nebivolol completely abolished blunting of the force-frequency relationship, which was observed in the sustained *OH injury phase. The results indicate that hydroxyl radical injury induces systolic and diastolic dysfunction, and that nebivolol can effectively prevent a large part of this *OH injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082203     DOI: 10.1016/s0014-2999(98)00907-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Impact of hydroxyl radical-induced injury on calcium handling and myofilament sensitivity in isolated myocardium.

Authors:  Kaylan M Haizlip; Nitisha Hiranandani; Brandon J Biesiadecki; Paul M L Janssen
Journal:  J Appl Physiol (1985)       Date:  2012-07-05

2.  Influence of oxygen free radicals on the tone of ciliary arteries: a model of vasospasms of ocular vasculature.

Authors:  Oliver Zeitz; Lars Wagenfeld; Nick Wirtz; Peter Galambos; Natalya Matthiesen; Anne Wiermann; Gisbert Richard; Maren Klemm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-25       Impact factor: 3.117

Review 3.  Future pharmacologic agents for treatment of heart failure in children.

Authors:  Brady S Moffett; Anthony C Chang
Journal:  Pediatr Cardiol       Date:  2006-08-23       Impact factor: 1.655

4.  Nebivolol decreases systemic oxidative stress in healthy volunteers.

Authors:  R Troost; E Schwedhelm; S Rojczyk; D Tsikas; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

5.  Effects of hydroxyl radical induced-injury in atrial versus ventricular myocardium of dog and rabbit.

Authors:  Nitisha Hiranandani; George E Billman; Paul M L Janssen
Journal:  Front Physiol       Date:  2010-09-30       Impact factor: 4.566

6.  The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells.

Authors:  R Preston Mason; Robert F Jacob; J Jose Corbalan; Damian Szczesny; Kinga Matysiak; Tadeusz Malinski
Journal:  BMC Pharmacol Toxicol       Date:  2013-09-28       Impact factor: 2.483

7.  Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model.

Authors:  Sabrina Stücker; Nico Kresin; Lucie Carrier; Felix W Friedrich
Journal:  Front Physiol       Date:  2017-08-02       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.